********KEEP ON THE WATCHLIST FOR BREAKOUT, IMPROVED TRIAL RESULTS RELEASED, WITH CONFERENCE CALL TO FOLLOW LATER IN THE DAY******* Achieve Life Sciences, Inc. ACHV, clinical-stage pharmaceutical company focused on nicotine addiction, today announced positive results from the ORCA-1 dose-selection trial of cytisinicline for smoking cessation. The outcome of the...
*******POSSIBLE BREAKOUT IN BIO STOCK WITH NICE PRICE ACTION, INCREASED INTEREST AMONG TRADERS AS RUMORS AND SPECULATION FOLLOW THIS STOCK, KEEP ON WATCHLIST FOR A RAPID MOVE*************** AVERAGE ANALYSTS PRICE TARGET $9 AVERAGE ANALYSTS RECOMMENDATION BUY COMPANY PROFILE OncoSec Medical, Inc. is a biotechnology company, which engages in...
******HOT STOCK ON THE WATCHLIST FOR THEY COMING DAYS, PURE SPECULATION AND RUMOR PICK, UNUSUAL BUY VOLUME AND PRICE SPIKE.********************** COMPANY PROFILE Xenetic Biosciences, Inc. engages in the discovery, research, and development of next generation biologic drugs and novel orphan oncology therapeutics. Its lead investigational product candidate is...
Keep on strong watch for continuation in KOOL in the coming days, todays advance was muted by other headline stock movements and strong volume in NDX and DJI. PRESS SOURCE MARKETWATCH Cesca Therapeutics Inc surged 11% in premarket trade Monday, after the provider of automated cell processing and point-of-care, autologous cell-based therapies said its...
===================== SPEX ( Spherix Incorporated) Float: 1.98M Alert Price: $2.97 CEO Interview Chart Analysis Website | Recent News ======================== Add SPEX to the top of your watchlist. See why this low-float alert could be the Nasdaq's top gainer Members, Earlier today we told you that we had a fresh low-float, Nasdaq listed...
AFTER A UNUSUAL 15% PRICE SPIKE ON FRIDAY ON HIGH VOLUME, THE STOCK OF NASDAQ:MHLD WILL BE ON STRONG WATCH FOR NEXT WEEK . INSIDERS HAVE BEEN BUYING THE STOCK AS HAVE INSTITUTIONAL INVESTORS SINCE LATE 2018. THE CHART IS TECHNICALLY SHOWING BULLISH DIVERGENCE SO KEEP ON THE WATCHLIST WITH ALERTS SET FOR VOLUME AND PRICE SPIKE . AVERAGE ANALYSTS PRICE TARGET ...
*****KEEP ON CLOSE WATCH FOR THE WEEKS TO COME FOR MASSIVE BREAKOUT AS A RESULT OF LICENCE APPLICATION******** Protalix BioTherapeutics and Chiesi Farmaceutici S.p.A to Apply for Accelerated Approval of pegunigalsidase alfa for the Treatment of Fabry Disease in the United States "We are very excited to be one step closer to an approved product to help a patient...
******HOT STOCK ON THE WATCHLIST FOR A SWING TRADE IN THE WEEKS TO COME, SPECULATION AND RUMORS HAVE BROUGHT IT THE ATTENTION OF MANY AND SOME ACCUMULATION HAS STARTED TO TAKE PLACE. JUST LIKE MOST BIO STOCKS, AMEX:OGEN TENDS TO MOVE VERY FAST FOR GREAT GAINS ON TRIAL AND DATA RELEASE, SO SET YOUR ALERTS FOR SPIKES. AVERAGE ANALYSTS PRICE TARGET ...
The cannabis bubble from last year, well and truly burst for NASDAQ:TLRY having ran to a post IPO price of $300 it reached a low of $34 within 1 year. The majority of cannabis stocks are in a bear market, as sentiment has turned very negative on the sector. This week TLRY has shown some signs of recovery but the stock is under pressure from all the MA'S and a...
*******HOT STOCK ON THE WATCHLIST FOR NEXT WEEK, STRENGTH HAS BEEN BUILDING IN NASDAQ:SELB SINCE JANUARY AND A BREAKOUT IS VERY POSSIBLE SOON. THE HISTOGRAM HAS GONE POSITIVE AND THE MACD IS ABOUT TO CROSS POSITIVELY, WHILE THE RSI IS AT A APEX AND LOOKS LIKE BREAKING OUT TO THE UPSIDE. ALERTS ARE SET FOR BREAK ABOVE THE 50MA WHICH IS CURRENTLY RESISTANCE BUT...
We are ignoring today's downgrade as having no significance, NYSE:CWH has been in free-fall for 2 years and despite the CEO buying shares and a hedge fund entering the stock it has failed to find a bottom. The company is on a aggressive restructuring and cost cutting strategy which will hopefully impact earnings in the next quarter. This could be a very...
NASDAQ:NEPT TODAY ANNOUNCED A 3 YEAR DEAL WITH NASDAQ:TLRY , THIS IS EXTREMELY POSITIVE AND LUCRATIVE FOR THE COMPANY, WE EXPECT THIS TO RUN MUCH HIGHER IN THE DAYS TO COME.
ALTHOUGH THE STOCK HAS JUMPED THIS WEEK, IT IS NOT TO LATE TO GET IN, BUYING PRESSURE IS IMMENSE AND THE STOCK HAS A EASY 50% UPSIDE POTENTIAL LEFT IN THE TANK, ON THE BACK OF GROWING EXPECTATION THE COMPANY WILL HAVE ITS FIRST APPROVED DRUG FOR SALE AND AT LAST GENERATE PROFITS . AVERAGE ANALYSTS PRICE TARGET $118 AVERAGE ANALYSTS RECOMMENDATION ...
This may be a little risky but we think it has a good risk reward with strong support below from channel, trend line and 100ma. Sentiment is quite mixed in the name and analysts quite split with upgrades and downgrades of estimates recently but we are bias to upside potential. AVERAGE ANALYSTS PRICE TARGET $241 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT...
THE COMPANY HAS LOST HALF OF IT VALUE TODAY, COULD BE VIEWED AS A EXTREME REACTION TO POOR EARNINGS AND OUTLOOK AS A RESULT OF WEATHER AND TARIFFS AMONG OTHERS. OPTION TRADERS HAVE SEEN A OPPORTUNITY TO ENTER A REVERSAL TRADE WITH 6 TIMES THE USUAL CALL BUYING TODAY WITH A $15 STRIKE IN SEPT 19, SUCH ACTIVITY CAN'T BE IGNORED. COMPANY PROFILE At Home Group,...
The companies recent earnings report was horrendous as was the outlook, that alone was a good reason to discard your stock but the news that the CEO was making a abrupt departure was a real alarm bell moment. The stock has been in a rapid decline since its IPO and has followed a pattern of sizable drops, this one may be much greater so don't try and catch the...
Earnings, sales and revenue were fine but it was the mention of taffies that sent the stock into the red, its is estimated that an increase in tariffs would result in a extra $25 million cost and result in a 3-4 % drag on earnings in 2019. This is not what investors want to hear as NASDAQ:FIVE is restricted by its name when it come to passing costs onto...
===================== HOTH (Hoth Therapeutics, Inc.) Float: 3.86M Alert Price: $6.57 Target Price: $10.00 Chart Analysis Investor Presentation Website | Recent News ======================== Members, We hope you enjoyed the easy double-digit gains that today's trade idea delivered. You'll be happy to know that we have already identified an...